In this blog, I’ve done many posts criticizing the way our regulators inhibited an effective response to Covid-19. They discouraged mask wearing, they discouraged Covid testing,...
Here’s an overview of the main factors that impacted the zinc market in H1 2021, and what’s ahead for the rest of the year. The post...
The current carrier stock forecast suggest this company may be the most attractive investment in the industrial sector right now. The post Carrier Stock Forecast: Most...
Gage Growth has a competitive edge in a blossoming industry. The post Lucrative stock opportunity as the MJ space experiences explosive growth in the US appeared...
After disappointing subscriber numbers in Q1, investors are looking for signs of improvement. Is this a good time to buy shares in Netflix? The post Netflix...
Australia Deports, Revokes Visa Of UK Commentator Katie Hopkins For Breaching Quarantine Authored by Henry Jom via The Epoch Times, British conservative commentator Katie Hopkins will...
What's Next For The Reflation Trade: 9 Observations From Goldman The rotation back into growth and defensive parts of the market and out of reflation and...
Looking to Make Money With Penny Stocks During a Down Market? Here's 3 Tips and Tricks The post How To Make Money With Penny Stocks In...
Wendell Cruz-USA TODAY SportsA very active weekend in the NL East, but for some much more positive news than other. The MLB Daily Dish is a...
Expansion plans shared by Regeneron call for the biotech giant to build approximately 900,000 square feet in two phases over six years, consisting of up to...
The rapid increase in demand for mRNA therapeutics has revealed the inherent challenge of the platform—that the production of mRNA is facing a series of bottlenecks....
Researchers at the Technical University of Munich have developed a method to create tiny virus traps that can bind viral particles and render them harmless within...
Scientists collaborate to model the complex protein responsible for SARS-CoV-2 replication, revealing its potential weak spots for drug development Credit: Greg Hura/Berkeley Lab In February 2020,...
America’s biopharmaceutical industry says it is “ready to do its part” in building a stronger, more resilient, affordable, The post Build back better: US pharma and...
Solar energy stocks have been consolidating over recent months, potentially providing a value opportunity for market participants looking to allocate new capital to names like Canadian...
The listing exercise raised $0.28 billion, of which $52.16 million was by issue of… The post CTOS Digital rises 60% in Bursa Malaysia debut first appeared...
Throughout the modern Olympic period, the host nation has had a home advantage. But crowds are not the only factor
Musicians, record labels and listeners could all be affected by sweeping changes to the music streaming industry.
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
Ongoing tracking is meant to spot very rare risks – like the connection between the Johnson & Johnson shot and Guillain-Barré syndrome. And it relies on...
LR: What is special about oneZero? What sets it apart from the other Liquidity Providers out there? Andrew: oneZero isn’t... The post Exclusive Interview: In talks...
Covid fears weighing on Asian markets Equity markets are front and centre in Asia this morning, as increasing nerves about the delta-variant Covid-19 are sapping recovery...
As the pandemic dwindled enough to get in our car with dogs, SiriusXM, and our children in the rear view mirror, we drove to South Carolina....
Temasek and Falcon Edge Capital have led a $220 million investment in Indian omni-channel eyewear retailer Lenskart, valuing the Bangalore-based startup at $2.5 billion. The new...
Experts in viral immunology, ethics and computational biology share their thoughts on England sloughing off the last of the COVID restrictions.
Overview: Concerns that the Delta mutation will slow or even reverse the recovery efforts appear to be sapping risk-taking appetites. Equities are under pressure. Nearly all...
Bioregnum Opinion Column by John Carroll Tillman Gerngross doesn’t waffle. The longtime Dartmouth professor and Adimab founder tends to pick a course and drive straight for...
Today we are pleased to present a guest contribution by Calla Wiemer (President, American Committee on Asian Economic Studies). Asian economies have been weathering the pandemic...
Will Biden Burst The Record M&A Bubble 2021 has been a blockbuster year for virtually every banking product: from IPOs and equity offerings, to investment grade...
Morgan Stanley: This Cycle Will Be "Hotter But Shorter" Than Usual By Andrew Sheets, Chief Cross-Asset Strategist for Morgan Stanley We think that this economic cycle...